Wave Life Sciences, Inc. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q3 2021 13F Holders as of 30 Sep 2021

Holder snapshot 7 signals
Share change
+447,622
Put/Call ratio
69%
SEC-reported price per share
$4.90
Number of holders
84
Value change
+$443,975
Number of buys
37
Open additional details 1 more signal available
Number of sells
39
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
188,679,245

Security key

Y95308105

Report period

Q3 2021

Institutions

84

Top holders

10

Ownership snapshot

Top reported holders of WVE - Wave Life Sciences, Inc. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Jun 2021
13F Highest disclosed value: $51,783,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $51.78M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $51.78M
DEERFIELD MANAGEMENT COMPANY, L.P. $32.16M
PRIMECAP MANAGEMENT CO/CA/ $30.55M
MAVERICK CAPITAL LTD $20.57M
BlackRock Finance, Inc. $18.91M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$51,783,000
7,775,207 shares
— 30 Jun 2021
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
13F
—
denominator unverified
$32,162,000
4,829,069 shares
— 30 Jun 2021
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
—
denominator unverified
$30,553,000
4,587,566 shares
— 30 Jun 2021
MAVERICK CAPITAL LTD
13F
Company
13F
—
denominator unverified
$20,567,000
3,088,131 shares
— 30 Jun 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$18,911,000
2,839,335 shares
— 30 Jun 2021
Bellevue Group AG
13F
Company
13F
—
denominator unverified
$17,335,000
2,602,858 shares
— 30 Jun 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
84
Shares
37,428,616
Rows available
84
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
82
Q3 2021 holders
84
Holder diff
2
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .